Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02133768
Other study ID # Bladder cathererisation
Secondary ID Lundbeck Foundat
Status Completed
Phase N/A
First received April 8, 2014
Last updated March 6, 2017
Start date May 2014
Est. completion date June 2016

Study information

Verified date March 2017
Source Lundbeck Foundation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To describe the need for re-catheterization and incidence of urological complications of routine use of perioperative fixed urinary catheter (KAD) for up to 24 hours of fast-track THA and TKA


Description:

Postoperative urinary retention (POUR) is a well known complication of fast-track total hip (THA) and knee arthroplasty (TKA), and even though medical options have been attempted, bladder catheterisation remains the only well-documented capacity to prevent and / or treat POUR.

It was previously standard to use fixed urinary catheter (KAD), the first 24-48 hours postoperatively to prevent POUR by THA and TKA, while more recent studies now recommend intermittent urinary catheterization in the postoperative period.

However, there are no detailed studies with adequate follow-up, describing the consequences of using either one or the other treatment regimen of POUR by fast-track THA and TKA.

Purpose:

To describe the need for re-catheterization and incidence of urological complications of routine use of perioperative fixed urinary catheter (KAD,catheter a demure) for up to 24 hours of fast-track THA and TKA

End Points:

1. The number of patients in need of re-catheterization due POUR

2. The number of patients in which the removal of KAD was not carried out within 24 hours.

3. The number of urinary tract infections from surgery to postoperative day (POD) 30

4. The number of patients with new-onset urinary discomfort at POD 30 (Increase in IPSS score).

5. The number of urological-related readmissions (including urosepsis) within POD 30


Recruitment information / eligibility

Status Completed
Enrollment 800
Est. completion date June 2016
Est. primary completion date May 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients must meet all the following criteria to be eligible to enroll in the study:

- Age >50 years.

- Patients scheduled for primary THA or TKA.

- Patients who have given verbal consent to participate in the study.

Exclusion Criteria:

- Patients who meet one or more of the following criteria may not be included in the study:

- Patients who can not cooperate with the study.

- Patients who do not understand or speak Danish.

- Patients who are permanent catheter carriers or use disposable bladder catheterisation.

- Patients on hemodialysis.

- Urine Derivative patients.

- Pregnancy or childbirth within 6 months.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Denmark Department of Orthopedic Holstebro Midtjylland

Sponsors (1)

Lead Sponsor Collaborator
Lundbeck Foundation

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients needing re-catheterization The need for re-catheterization will be asses on a daily basis until discharge from hospital (median 3 days from surgery) From removal of urinary catheter at first postoperative day and untill discharge from hospital
Secondary Number of patients who did not get their urinary catheter removed on the first postoperative day within the first 24 hours after surgery
Secondary Number of urinary tract infections Assessed on a daily basis during admision and detailed telephone interview on day 30 after surgery within the first 30 days after surgery
Secondary Number of patients developing postoperative micturition difficulties All patients completes a questionary preoperatively (the international prostate symptom score) and the same questionary again on day 30 after surgery. From day 1 to day 30 after surgery
Secondary Number of re-admission due to urological problems, including urosepsis assessed by telephone interview on day 30 after surgery within the first 30 days after surgery
See also
  Status Clinical Trial Phase
Completed NCT03341819 - Comparative Study Between Retained and Non-retained Urinary Catheter in Total Knee Arthorplasty With Epidural Anesthesia N/A
Completed NCT05428020 - RCT Foley Catheter Study for Elective TJA N/A
Completed NCT05969145 - The Effect of Hot-Cold Application to the Bladder After Orthopedic Surgery on Postoperative Urinary Retention N/A
Terminated NCT01568918 - Use of Tamsulosin to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery Phase 3
Completed NCT05898919 - Acupuncture for Postoperative Urinary Retention After Hemorrhoidectomy: a Randomized Controlled Trial Phase 2
Completed NCT02958878 - Preoperative Administration of Tamsulosin for Prevention of Post Operative Urinary Retention in Males Undergoing Elective Inguinal Hernia Repair Phase 4
Completed NCT02996968 - Self-discontinuation of a Transurethral Catheter N/A
Withdrawn NCT03937531 - Void Trials After Two Voiding Trials (TVT) N/A
Recruiting NCT05664633 - The Role of Sugammadex in Posotoperative Urinary Retention in Patients Undergoing Pelvic Floor Reconstructive Procedures Phase 1/Phase 2
Terminated NCT02518971 - Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients Phase 3
Recruiting NCT05276804 - The POUR (Postoperative Urinary Retention) Study Phase 3
Not yet recruiting NCT06258785 - Effect of Tizanidine on Postoperative Urinary Retention After Sacrospinous Suspension Phase 3